Evidence map›Paper›PMID 42575946›Full record

ArticleNature computational science2026

Robust out-of-distribution prediction of Buchwald-Hartwig reactions.

Paulo Neves, Bo Hao, Santeri Aikonen, Justin B Diccianni, Jörg K Wegner, Philippe Schwaller, Iulia I Strambeanu

Abstract read
In one paragraph

Article in Nature computational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulo Neves *Drug Discovery Data Science, In Silico Discovery, Johnson & Johnson, Porto Salvo, Portugal.ORCID http://orcid.org/0000-0001-9556-6418
Bo Hao *Chemistry Capabilities, Analytical and Purification, Global Discovery Chemistry, Johnson & Johnson, Spring House, PA, USA.
Santeri Aikonen *Drug Discovery Data Science, In Silico Discovery, Johnson & Johnson, Spring House, PA, USA.ORCID http://orcid.org/0000-0003-2675-7290
Justin B DiccianniChemistry Capabilities, Analytical and Purification, Global Discovery Chemistry, Johnson & Johnson, Spring House, PA, USA.ORCID http://orcid.org/0009-0005-2922-6868
Jörg K WegnerDrug Discovery Data Science, In Silico Discovery, Johnson & Johnson, Cambridge, MA, USA. jwegner@its.jnj.com.
Philippe SchwallerLaboratory of Artificial Chemical Intelligence (LIAC), Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. philippe.schwaller@epfl.ch.ORCID http://orcid.org/0000-0003-3046-6576
Iulia I StrambeanuChemistry Capabilities, Analytical and Purification, Global Discovery Chemistry, Johnson & Johnson, Spring House, PA, USA. istrambe@its.jnj.com.ORCID http://orcid.org/0000-0002-1502-5484

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Buchwald-Hartwig cross-coupling is a cornerstone of modern pharmaceutical synthesis, yet predictive modeling of its outcomes remains constrained by data quality and chemical space coverage. Electronic laboratory notebooks contain heterogeneous, noisy records, while open-source high-throughput experimentation (HTE) datasets are fragmented and narrow in scope, leading to poor model performance on unseen substrates and conditions. Here we introduce a framework that systematically standardizes and integrates multiple reaction datasets into a high-quality, unique-structure-per-entity dataset, coupled with active learning to strategically expand chemical space. By merging published Buchwald-Hartwig HTE data with new experimental results, we achieve a model with predictive power across novel substrates and conditions, delivering improved out-of-distribution predictions compared with previous approaches. Crucially, model-guided reagent recommendations were validated experimentally, confirming the framework's utility to uncover unexplored reactivity. This work establishes a blueprint for robust machine learning in synthetic chemistry and enables preemptive in silico reagent screening to accelerate pharmaceutical discovery.

Identifiers

PMID42575946
PMCPMC13593570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.